title: The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
authors.affiliation: Hunter Area Pathology Service, John Hunter Hospital, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia. huy.tran@hnehealth.nsw.gov.au
authors.forename: H A
authors.initials: HA
authors.lastname: Tran
authors.forename: E A
authors.initials: EA
authors.lastname: Ianna
authors.forename: T L
authors.initials: TL
authors.lastname: Jones
authors.forename: G E M
authors.initials: GE
authors.lastname: Reeves
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000139:chemically induced / Q000188:drug therapy; D013974:Thyroxine / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin; D013974:Thyroxine